Showing 21,021 - 21,040 results of 30,146 for search '(( significant decrease decrease ) OR ( significant ((largest decrease) OR (year increase)) ))*', query time: 0.63s Refine Results
  1. 21021

    Table 7_Spatial transcriptomics and in situ immune cell profiling of the host ectocervical landscape of HIV infected Kenyan sex working women.xlsx by Mathias Franzén Boger (12519539)

    Published 2024
    “…MELC analysis further revealed a significantly increased ectocervical leukocyte population in HIV-seropositive participants, primarily driven by an increase in CD8<sup>+</sup> T cells while the CD4<sup>+</sup> T cell population remained stable. …”
  2. 21022

    Table 1_Spatial transcriptomics and in situ immune cell profiling of the host ectocervical landscape of HIV infected Kenyan sex working women.xlsx by Mathias Franzén Boger (12519539)

    Published 2024
    “…MELC analysis further revealed a significantly increased ectocervical leukocyte population in HIV-seropositive participants, primarily driven by an increase in CD8<sup>+</sup> T cells while the CD4<sup>+</sup> T cell population remained stable. …”
  3. 21023

    Image 1_The correlation between TyG-BMI and the risk of osteoporosis in middle-aged and elderly patients with type 2 diabetes mellitus.tiff by Yanrong Chen (2611009)

    Published 2025
    “…</p>Methods<p>This retrospective cross-sectional study enrolled 386 inpatients with T2DM, comprising both male and postmenopausal female participants aged 40 years or older. Individuals with significant medical histories or medications known to influence bone mineral density were excluded. …”
  4. 21024

    Data Sheet 1_Spatial transcriptomics and in situ immune cell profiling of the host ectocervical landscape of HIV infected Kenyan sex working women.pdf by Mathias Franzén Boger (12519539)

    Published 2024
    “…MELC analysis further revealed a significantly increased ectocervical leukocyte population in HIV-seropositive participants, primarily driven by an increase in CD8<sup>+</sup> T cells while the CD4<sup>+</sup> T cell population remained stable. …”
  5. 21025

    Image 2_The correlation between TyG-BMI and the risk of osteoporosis in middle-aged and elderly patients with type 2 diabetes mellitus.tiff by Yanrong Chen (2611009)

    Published 2025
    “…</p>Methods<p>This retrospective cross-sectional study enrolled 386 inpatients with T2DM, comprising both male and postmenopausal female participants aged 40 years or older. Individuals with significant medical histories or medications known to influence bone mineral density were excluded. …”
  6. 21026

    Table 3_Spatial transcriptomics and in situ immune cell profiling of the host ectocervical landscape of HIV infected Kenyan sex working women.xlsx by Mathias Franzén Boger (12519539)

    Published 2024
    “…MELC analysis further revealed a significantly increased ectocervical leukocyte population in HIV-seropositive participants, primarily driven by an increase in CD8<sup>+</sup> T cells while the CD4<sup>+</sup> T cell population remained stable. …”
  7. 21027

    Image 3_The correlation between TyG-BMI and the risk of osteoporosis in middle-aged and elderly patients with type 2 diabetes mellitus.tiff by Yanrong Chen (2611009)

    Published 2025
    “…</p>Methods<p>This retrospective cross-sectional study enrolled 386 inpatients with T2DM, comprising both male and postmenopausal female participants aged 40 years or older. Individuals with significant medical histories or medications known to influence bone mineral density were excluded. …”
  8. 21028

    Table 1_Association between estimated glucose disposal rate and preserved ratio impaired spirometry in adults.xlsx by Tong Lin (33562)

    Published 2025
    “…Subgroup analyses demonstrated a stronger association between eGDR and PRISm in females and individuals over 40 years of age. The restricted cubic spline analysis indicated a significant non-linear relationship, with an optimal eGDR cutoff of 11.423 mg/kg/min identified via ROC analysis (AUC = 0.626), demonstrating modest predictive accuracy.…”
  9. 21029

    Table 2_Spatial transcriptomics and in situ immune cell profiling of the host ectocervical landscape of HIV infected Kenyan sex working women.xlsx by Mathias Franzén Boger (12519539)

    Published 2024
    “…MELC analysis further revealed a significantly increased ectocervical leukocyte population in HIV-seropositive participants, primarily driven by an increase in CD8<sup>+</sup> T cells while the CD4<sup>+</sup> T cell population remained stable. …”
  10. 21030

    Table 5_Spatial transcriptomics and in situ immune cell profiling of the host ectocervical landscape of HIV infected Kenyan sex working women.xlsx by Mathias Franzén Boger (12519539)

    Published 2024
    “…MELC analysis further revealed a significantly increased ectocervical leukocyte population in HIV-seropositive participants, primarily driven by an increase in CD8<sup>+</sup> T cells while the CD4<sup>+</sup> T cell population remained stable. …”
  11. 21031

    Table 4_Arginine supplementation improves lactate dehydrogenase levels in steady-state sickle cell patients: preliminary findings from Kinshasa, the Democratic Republic of Congo.do... by Ange C. M. Ngonde (20311575)

    Published 2024
    “…</p>Results<p>The cohort had a median age of 12 years, ranging from 2 to 43 years. Throughout all three phases of the study, lactate dehydrogenase (LDH) levels were consistently above the established normal ranges, with elevations of 216.7%, 220.3% and 176.6% above the normative values for baseline, Phase 1 (HU) and Phase 2 (HU + Arg), respectively. …”
  12. 21032

    Table 1_Global, regional and national burden of inflammatory bowel disease in females from 1990 to 2021: an analysis of the global burden of disease study 2021.docx by Jingyi Peng (4568566)

    Published 2025
    “…Incidence rates were highest among females aged 30–60, with disease burden increasing significantly with age in older populations. …”
  13. 21033

    Data Sheet 3_Arginine supplementation improves lactate dehydrogenase levels in steady-state sickle cell patients: preliminary findings from Kinshasa, the Democratic Republic of Con... by Ange C. M. Ngonde (20311575)

    Published 2024
    “…</p>Results<p>The cohort had a median age of 12 years, ranging from 2 to 43 years. Throughout all three phases of the study, lactate dehydrogenase (LDH) levels were consistently above the established normal ranges, with elevations of 216.7%, 220.3% and 176.6% above the normative values for baseline, Phase 1 (HU) and Phase 2 (HU + Arg), respectively. …”
  14. 21034

    Data Sheet 1_Arginine supplementation improves lactate dehydrogenase levels in steady-state sickle cell patients: preliminary findings from Kinshasa, the Democratic Republic of Con... by Ange C. M. Ngonde (20311575)

    Published 2024
    “…</p>Results<p>The cohort had a median age of 12 years, ranging from 2 to 43 years. Throughout all three phases of the study, lactate dehydrogenase (LDH) levels were consistently above the established normal ranges, with elevations of 216.7%, 220.3% and 176.6% above the normative values for baseline, Phase 1 (HU) and Phase 2 (HU + Arg), respectively. …”
  15. 21035

    Table 5_Arginine supplementation improves lactate dehydrogenase levels in steady-state sickle cell patients: preliminary findings from Kinshasa, the Democratic Republic of Congo.do... by Ange C. M. Ngonde (20311575)

    Published 2024
    “…</p>Results<p>The cohort had a median age of 12 years, ranging from 2 to 43 years. Throughout all three phases of the study, lactate dehydrogenase (LDH) levels were consistently above the established normal ranges, with elevations of 216.7%, 220.3% and 176.6% above the normative values for baseline, Phase 1 (HU) and Phase 2 (HU + Arg), respectively. …”
  16. 21036

    Data Sheet 2_Arginine supplementation improves lactate dehydrogenase levels in steady-state sickle cell patients: preliminary findings from Kinshasa, the Democratic Republic of Con... by Ange C. M. Ngonde (20311575)

    Published 2024
    “…</p>Results<p>The cohort had a median age of 12 years, ranging from 2 to 43 years. Throughout all three phases of the study, lactate dehydrogenase (LDH) levels were consistently above the established normal ranges, with elevations of 216.7%, 220.3% and 176.6% above the normative values for baseline, Phase 1 (HU) and Phase 2 (HU + Arg), respectively. …”
  17. 21037

    Data Sheet 4_Arginine supplementation improves lactate dehydrogenase levels in steady-state sickle cell patients: preliminary findings from Kinshasa, the Democratic Republic of Con... by Ange C. M. Ngonde (20311575)

    Published 2024
    “…</p>Results<p>The cohort had a median age of 12 years, ranging from 2 to 43 years. Throughout all three phases of the study, lactate dehydrogenase (LDH) levels were consistently above the established normal ranges, with elevations of 216.7%, 220.3% and 176.6% above the normative values for baseline, Phase 1 (HU) and Phase 2 (HU + Arg), respectively. …”
  18. 21038

    Table 1_Arginine supplementation improves lactate dehydrogenase levels in steady-state sickle cell patients: preliminary findings from Kinshasa, the Democratic Republic of Congo.do... by Ange C. M. Ngonde (20311575)

    Published 2024
    “…</p>Results<p>The cohort had a median age of 12 years, ranging from 2 to 43 years. Throughout all three phases of the study, lactate dehydrogenase (LDH) levels were consistently above the established normal ranges, with elevations of 216.7%, 220.3% and 176.6% above the normative values for baseline, Phase 1 (HU) and Phase 2 (HU + Arg), respectively. …”
  19. 21039

    Table 7_Arginine supplementation improves lactate dehydrogenase levels in steady-state sickle cell patients: preliminary findings from Kinshasa, the Democratic Republic of Congo.do... by Ange C. M. Ngonde (20311575)

    Published 2024
    “…</p>Results<p>The cohort had a median age of 12 years, ranging from 2 to 43 years. Throughout all three phases of the study, lactate dehydrogenase (LDH) levels were consistently above the established normal ranges, with elevations of 216.7%, 220.3% and 176.6% above the normative values for baseline, Phase 1 (HU) and Phase 2 (HU + Arg), respectively. …”
  20. 21040

    Table 8_Arginine supplementation improves lactate dehydrogenase levels in steady-state sickle cell patients: preliminary findings from Kinshasa, the Democratic Republic of Congo.do... by Ange C. M. Ngonde (20311575)

    Published 2024
    “…</p>Results<p>The cohort had a median age of 12 years, ranging from 2 to 43 years. Throughout all three phases of the study, lactate dehydrogenase (LDH) levels were consistently above the established normal ranges, with elevations of 216.7%, 220.3% and 176.6% above the normative values for baseline, Phase 1 (HU) and Phase 2 (HU + Arg), respectively. …”